New study aims to save Children's eyesight and lives from eye cancer in africa

NCT ID NCT04425434

Recruiting now Disease control Sponsor: French Africa Pediatric Oncology Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to improve survival and care for children with retinoblastoma, a rare eye cancer, in low-income African countries. Researchers will test whether following a set of treatment guidelines helps catch the disease early and leads to better outcomes. The study will enroll up to 3,000 children and track how many are diagnosed, what treatments they receive, and how many survive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinoblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINOBLASTOMA

Contacts and locations

Locations

CHU Gabriel Touré (HGT)
RECRUITING

Bamako, Mali
CHU de Treichville à ABIDJAN
RECRUITING

Abidjan, Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
RECRUITING

Kinshasa, Kinshasa City, BP 12 KIN XI, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
RECRUITING

Lubumbashi, BP 1825, Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
RECRUITING

Antananarivo, Ampefiloha, BP 4150, Madagascar
Hopital Yalgado Ouedraogo
RECRUITING

Ouagadougou, 03 BP 7022, Burkina Faso
Hôpital Aristide Le Dantec,
RECRUITING

Dakar, BP 3001, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.